## **Core Concept**
The question tests knowledge on the prophylaxis of meningococcal meningitis, specifically focusing on chemoprophylaxis for close contacts of a patient with the disease. Meningococcal meningitis is caused by *Neisseria meningitidis*, and prophylaxis aims to prevent secondary cases among close contacts.

## **Why the Correct Answer is Right**
Ceftriaxone is a third-generation cephalosporin with potent activity against *Neisseria meningitidis*. It is administered as a single dose for prophylaxis, making it highly effective and convenient for preventing meningococcal disease among close contacts. The mechanism involves inhibiting bacterial cell wall synthesis, leading to bactericidal activity against *N. meningitidis*.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Ciprofloxacin, a fluoroquinolone, can be used for prophylaxis but is not the first choice, especially in areas with high resistance rates or in certain populations like pregnant women.
* **Option B:** Rifampicin (rifampin) is a classic choice for chemoprophylaxis against meningococcal disease but can have significant drug interactions and side effects. It requires multiple doses.
* **Option D:** Azithromycin is a macrolide antibiotic and not typically used for *N. meningitidis* prophylaxis.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that chemoprophylaxis for close contacts of patients with meningococcal meningitis is crucial to prevent secondary cases. Ceftriaxone, given as a single dose, is highly effective and recommended, especially for individuals who cannot tolerate or have contraindications to other prophylactic options like rifampicin.

## **Correct Answer:** . Ceftriaxone